# Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer

> **NCT07025850** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **DRUG:** Digoxin
- **DRUG:** Fuquinitinib
- **DRUG:** Tislelizumab

## Key facts

- **NCT ID:** NCT07025850
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07025850

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07025850, "Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT07025850. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*